GlassScriptPhysician profile
Richard J Beckerman
NPI 1013061886
$2,782.47
in general payments reported to CMS, 2019-2025
34 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,010 · 2020: $261 · 2021: $98.78 · 2022: $253 · 2023: $531 · 2024: $302 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,080 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,080.08 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $505.52 | 2019-2025 | Veozah |
| Abbvie INC. | $347.47 | 2019-2023 | Lo Loestrin Fe, Liletta |
| Pfizer INC. | $238.40 | 2019-2024 | |
| Coopersurgical, INC. | $177.35 | 2019-2024 | Paragard T 380a, Paragard T 380a, Endosee |
| Hologic Sales and Service, LLC | $165.07 | 2023-2025 | Aptima, Coolseal Generator, Acessa Provu System |
| Renovia INC | $161.22 | 2019 | |
| Myriad Women'S Health, INC. | $156.27 | 2023 | Myrisk |
| Bayer Healthcare Pharmaceuticals INC. | $105.77 | 2019-2025 | |
| Therapeuticsmd, INC. | $89.21 | 2019-2020 | |
| Millicent US INC | $84.87 | 2019-2025 | Femlyv, Intrarosa, Femring |
| Duchesnay USA Incorporated | $61.23 | 2019 | |
| Merck Sharp & Dohme LLC | $54.76 | 2019 | |
| Sage Therapeutics, LLC | $54.09 | 2024 | |
| Sumitomo Pharma America, INC. | $47.97 | 2023-2024 | Myfembree |
| Myovant Sciences INC. | $45.25 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $43.65 | 2019 | |
| Amag Pharmaceuticals, INC. | $42.83 | 2019 | |
| Aspira Women'S Health INC | $40.34 | 2022-2023 | Ova1 |
| Allergan, INC. | $39.49 | 2019-2020 | |
| Avion Pharmaceuticals | $38.04 | 2019-2020 | |
| Aesculap, INC. | $35.47 | 2019 | |
| Amgen INC. | $34.31 | 2019 | |
| Radius Health, INC. | $33.16 | 2025 | Tymlos |
| Exeltis, USA INC. | $21.38 | 2022 | |
| Ferring Pharmaceuticals INC. | $20.55 | 2019 | |
| Biogen, INC. | $19.48 | 2023 | |
| Novartis Pharmaceuticals Corporation | $19.29 | 2022 | |
| Becton, Dickinson and Company | $17.97 | 2024 | Bd Max System, Bd Max Instrument |
| Exact Sciences Corporation | $16.83 | 2025 | The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.13 | 2019 | |
| Optumhealth Care Solutions, LLC | $15.13 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Minerva Surgical, INC | $13.44 | 2022 | |
| Organon LLC | $11.41 | 2024 | |
| Bolder Surgical LLC | $10.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Beckerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.